|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.57 USD | +11.35% |
|
+12.14% | -21.11% |
| 04-26 | Exagen Inc. Announces Changes in Board of Directors | CI |
| 03-18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Exagen Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 13.77 million compared to USD 12.84 million a year ago. Net loss was USD 5.57 million compared to USD 14.35 million a year ago.
Basic loss per share from continuing operations was USD 0.31 compared to USD 0.83 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.11% | 27.25M | |
| +20.68% | 85.55B | |
| -29.31% | 70.07B | |
| +9.65% | 29.06B | |
| -8.63% | 17.51B | |
| +2.14% | 17.39B | |
| +0.39% | 15.38B | |
| +6.47% | 13.4B | |
| +68.09% | 12.87B | |
| +6.43% | 12.77B |
EXAGEN INC. 
